A Phase 1 oncology study went from kick-off to go-live in just 5 weeks, offering valuable lessons for accelerating study start-up.
How Kayentis Delivered eCOA Go-Live in Just 5 Weeks for a Phase 1 Oncology Study
The following best practices highlight how early planning, clear governance, and close sponsor-vendor collaboration can accelerate timelines while maintaining high quality:
1. Engage eCOA Vendors Early
Early vendor engagement allows key decisions and potential risks to be identified before they become timeline-critical issues. Bringing the eCOA vendor into protocol discussions, endpoint strategy conversations, and study planning activities enables:
- Earlier assessment of protocol complexity and potential implementation challenges.
- Identification of required platform features and integrations.
- Improved timeline forecasting and resource planning.
- Opportunities to leverage previously implemented solutions and reusable assets.
The earlier the vendor is engaged, the more opportunity exists to optimize study design and reduce downstream amendments or rework.
2. Establish a Clear Licensing Strategy
Licensing is frequently one of the most significant drivers of study start-up timelines for eCOA studies utilizing copyrighted instruments.
Sponsors can help mitigate delays by:
- Developing a licensing plan as early as possible.
- Identifying all required clinical outcome assessments during study planning.
- Engaging copyright holders early.
- Clearly defining ownership and responsibilities for licensing activities.
Even when the eCOA vendor is not directly coordinating licensing activities, maintaining transparency and visibility into the licensing process is essential. Vendors should be informed of licensing status, expected approval dates, and any instrument-specific requirements that may impact implementation.
Early visibility allows vendors to appropriately plan build activities and avoid last-minute delays.
3. Come Prepared to the Kick-Off Meeting
A productive kick-off meeting can significantly accelerate project execution.
Sponsors should arrive with a clear understanding of:
- Required study workflows
- Endpoint collection strategies
- Device requirements
- Visit schedules
- Desired eCOA platform features and functionality
Organizations that have prior experience with a vendor often achieve faster study start-up because they are familiar with available platform capabilities and can make informed decisions more quickly.
This preparation minimizes discovery cycles and reduces the number of design iterations required during study setup.
4. Build Organizational Knowledge of eCOA Capabilities
One common challenge in large organizations is knowledge fragmentation. Teams may be unaware of capabilities that have already been successfully implemented on other studies.
Sponsors can benefit from establishing governance structures that:
- Promote knowledge sharing across studies and programs.
- Maintain internal awareness of vendor feature releases and platform enhancements.
- Capture lessons learned from previous implementations.
- Create reusable standards and best practices.
Organizations that actively share knowledge are better positioned to leverage existing capabilities rather than requesting custom solutions that may increase complexity and timelines.
5. Think at the Program Level, Not Just the Study Level
Significant efficiencies can be realized when sponsors adopt a program-based approach to eCOA implementation.
When studies within a development program reuse:
- Patient-reported outcome instruments
- Clinician-reported outcome instruments
- Visit schedules
- Workflow designs
- Device strategies
vendors can often leverage previously configured and validated components.
Benefits include:
- Reduced build effort
- Faster design reviews
- Lower risk of inconsistencies across studies
- Potential cost savings
- Accelerated deployment timelines
Particularly for licensed scales, reusing previously implemented instruments can generate substantial efficiencies and reduce overall study start-up risk.
6. Foster a Collaborative Partnership Model
The fastest and most successful implementations occur when sponsors and vendors operate as strategic partners rather than transactional suppliers.
This includes:
- Timely decision-making
- Rapid review and approval cycles
- Transparent communication regarding risks and dependencies
- Regular governance meetings
- Alignment on critical milestones
A collaborative approach enables issues to be identified and resolved quickly, helping maintain momentum throughout study start-up.
